| Filed On | Filing |
|---|---|
| 12 Sep 2025 |
8-K/A: Financial Statements and Exhibits
On July 8, 2024, ReShape, Vyome, and Merger Sub, entered into the Merger Agreement (“Merger”). Pursuant to the Merger Agreement, and subject to the satisfaction or waiver of the conditions specified therein, Merger Sub shall be merged wi... |
| 22 Mar 2022 |
8-K/A: Results of Operations and Financial Condition
Full Year Revenue Increased by Approximately 20%, from $11.3 M to $13.6 M |
| 30 May 2019 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On May 22, 2019, Obalon Therapeutics, Inc. (the “Company”) filed a Form 8-K with the U.S. Securities and Exchange Commission (the “Original Report”) to report that Kelly Huang had notified the Board of Directors (the “Board”) of his resi... |
Loading...